Carmen Valcarce

EVP, Chief Scientific Officer at vTv Therapeutics

Carmen has more than 30 years of pharmaceutical research and development experience focused in the metabolic space. During her career, Carmen has managed more than 12 INDs and has run numerous positive clinical studies. Carmen was a member of the vTv IPO team, having joined the company from Novo Nordisk as a result of vTv’s former partnership with Novo. Carmen is an inventor on more than 20 patents and patent applications and an author on numerous peer-reviewed scientific publications. Carmen obtained her Ph.D. at the Universidad Autonoma de Madrid, Spain in 1988 under the direction of Prof. Jose M. Cuezva in the field of metabolic diseases.


Previous companies

Novo Nordisk logo


  • EVP, Chief Scientific Officer

    Current role